Streamline process development with authenticated cell lines and known sources of potential contamination. Gene expression and dPCR enable highly specific and sensitive detection, identification, and quantitation of microbial strains and residual vector DNA. Allelic discrimination is a straightforward approach to assess cell lines for authenticity, provenance, and long-term genetic stability.
Detect microbial targets at the lowest limits, even in the presence of common inhibitors, to help produce microbe-free drugs and therapeutics with confidence.
Residual vector quantification
Quantify absolute viral vector titers in your cell cultures to determine concentrations of your biotherapeutic for use in gene and cell therapies.
Cell line quality control
Speed development of new approaches to cell-based therapeutics with authenticated cell lines and confirm the identity of your human cultured cells with confidence with short tandem repeat (STR) genotyping.
- E-Book: Genetic Insights for biopharmaceuticals: Propelling drug candidates into therapeutic assets
- Whitepaper: QC for ex vivo manipulated cell lines and tissues
- Webinar: Gene editing – the precision tool for tomorrow’s treatments
- Blog Post: The role of capillary electrophoresis in drug development
- Blog Post: Sanger sequencing for quality control in AAV vector production
Poster: PCR system for consistent viral titer quantification
Monoclonal antibody development
Efficiently develop and characterize recombinant monoclonal antibodies (mAbs) from discovery through clinical trials and manufacturing by incorporating genetic-level analysis into your workflows.